Microbes and asthma: Opportunities for intervention

Slides:



Advertisements
Similar presentations
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Advertisements

Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema  Pasi Lehtinen, MD, Aino Ruohola,
Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease?  Young J. Juhn, MD, MPH  Journal.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Clarification concerning amoxicillin skin testing
Fatty acids, inflammation, and asthma
Obstructive sleep apnea syndrome and inflammation
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
The microbiome in allergic disease: Current understanding and future opportunities— 2017 PRACTALL document of the American Academy of Allergy, Asthma &
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Fatty acids, inflammation, and asthma
Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: A prospective cohort study  Astrid S. Peters, MD, MSc, Jessica.
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children  Kevin R. Murphy, MD, Robert.
Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies.
The National Biome Initiative: An allergy perspective
Furry pets modulate gut microbiota composition in infants at risk for allergic disease  Merja Nermes, MD, PhD, Akihito Endo, PhD, Jasmin Aarnio, BM, Seppo.
Nonadherence to Asthma Treatment: Getting Unstuck
Etiology of asthma exacerbations
United Nations Climate Change Conferences: COP21 a lost opportunity for asthma and allergies and preparing for COP22  Isabella Annesi-Maesano, MD, PhD,
The future of allergy/immunology: Promising young investigators
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Reply Journal of Allergy and Clinical Immunology
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Phillip Lieberman, MD, Michael Tankersley, MD 
Environmental determinants of allergy and asthma in early life
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Charles E. Reed, MD, Hirohito Kita, MD 
What are the best outcome measurements for atopic eczema
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Aaron M. Drucker, MD, Paula J. Harvey, PhD 
Opposite effects of CD14/-260 on serum IgE levels in children raised in different environments  Waltraud Eder, MD, Walt Klimecki, PhD, Lizhi Yu, MD, Erika.
Geographic variability in childhood asthma prevalence in Chicago
A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children  Felicia A. Rabito, PhD, MPH, John C. Carlson,
Felicia A. Rabito, PhD, Shahed Iqbal, PhD, Michael P
One step forward, 2 steps back: The enigma of preschool wheeze
Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma  Isabelle Romieu, MD, MPH, ScD, Albino Barraza-Villarreal,
Thomas Gensollen, PhD, Richard S. Blumberg, MD 
Erika von Mutius, MD, MSc  Journal of Allergy and Clinical Immunology 
A simulation model of building intervention impacts on indoor environmental quality, pediatric asthma, and costs  Maria Patricia Fabian, ScD, Gary Adamkiewicz,
Innate immune responses to infection
Thunderstorm-related asthma attacks
Lars Pedersen, MD, PhD, Thomas K
Measles and immunomodulation
Asthma progression: Can we and should we measure it?
Harald Renz, MD, Ingo B. Autenrieth, MD, Per Brandtzæg, PhD, William O
Increased food diversity in the first year of life is inversely associated with allergic diseases  Caroline Roduit, MD, MPH, Remo Frei, PhD, Martin Depner,
Macrolide antibiotics and asthma treatment
The neonatal window of opportunity—early priming for life
Asthma: The past, future, environment, and costs
Leonie Hussaarts, MSc, Luciën E. P. M
The environmental predictors of allergic disease
Tuomas Jartti, MD, James E. Gern, MD 
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists  Michael Schatz, MD, MS, Christine.
Environmental factors and eosinophilic esophagitis
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Microbes and asthma: Opportunities for intervention Hermelijn H. Smits, PhD, Pieter S. Hiemstra, PhD, Clarissa Prazeres da Costa, MD, PhD, Markus Ege, MPH, Michael Edwards, PhD, Holger Garn, PhD, Peter H. Howarth, MD, Tuomas Jartti, MD, Esther C. de Jong, PhD, Rick M. Maizels, PhD, Ben J. Marsland, PhD, Henry J. McSorley, PhD, Anne Müller, PhD, Petra I. Pfefferle, PhD, Huub Savelkoul, PhD, Jürgen Schwarze, MD, Wendy W.J. Unger, PhD, Erika von Mutius, MD, MSc, Maria Yazdanbakhsh, PhD, Christian Taube, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 137, Issue 3, Pages 690-697 (March 2016) DOI: 10.1016/j.jaci.2016.01.004 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Journal of Allergy and Clinical Immunology 2016 137, 690-697DOI: (10 Journal of Allergy and Clinical Immunology 2016 137, 690-697DOI: (10.1016/j.jaci.2016.01.004) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Schematic overview of the hygiene/“old friends” hypothesis. Several microbial signals, such as environmental exposure (rural/farm environment) and an archaic microbiota (containing more diverse and abundant bacteria and typical helminth parasites), provide strong signals to develop regulatory responses (tolerance), whereas an urbanized environment and/or a westernized microbiota does not, tipping the immune balance more toward inflammation. Tolerance leads to good health, whereas in its absence, an inflammatory profile leads to airway diseases, such as respiratory allergies and asthma. Composition and diversity of the microbiota are affected by diet. Viral infections, sinusitis, and air pollution trigger the immune system to move toward inflammation, whereas a diverse microbiota might reduce these inflammatory signals. Journal of Allergy and Clinical Immunology 2016 137, 690-697DOI: (10.1016/j.jaci.2016.01.004) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions